J. Martijn Bos

12.1k total citations
173 papers, 5.5k citations indexed

About

J. Martijn Bos is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, J. Martijn Bos has authored 173 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 159 papers in Cardiology and Cardiovascular Medicine, 66 papers in Molecular Biology and 17 papers in Epidemiology. Recurrent topics in J. Martijn Bos's work include Cardiac electrophysiology and arrhythmias (89 papers), Cardiomyopathy and Myosin Studies (72 papers) and Cardiovascular Effects of Exercise (41 papers). J. Martijn Bos is often cited by papers focused on Cardiac electrophysiology and arrhythmias (89 papers), Cardiomyopathy and Myosin Studies (72 papers) and Cardiovascular Effects of Exercise (41 papers). J. Martijn Bos collaborates with scholars based in United States, Netherlands and Italy. J. Martijn Bos's co-authors include Michael J. Ackerman, Steve R. Ommen, Jeffrey A. Towbin, Bernard J. Gersh, David J. Tester, Jeanne L. Theis, Iacopo Olivotto, Franco Cecchi, Stefano Nistri and Ram K. Rohatgi and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

J. Martijn Bos

164 papers receiving 5.4k citations

Peers

J. Martijn Bos
Jens Mogensen Denmark
Juan R. Gimeno Spain
Philippe Charron France
Andrea Mazzanti Italy
Nathan Mewton France
Juha Koskenvuo Finland
Mika Laine Finland
Yüng-Zu Tseng Taiwan
Dana Leifer United States
Vincent Probst France
Jens Mogensen Denmark
J. Martijn Bos
Citations per year, relative to J. Martijn Bos J. Martijn Bos (= 1×) peers Jens Mogensen

Countries citing papers authored by J. Martijn Bos

Since Specialization
Citations

This map shows the geographic impact of J. Martijn Bos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Martijn Bos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Martijn Bos more than expected).

Fields of papers citing papers by J. Martijn Bos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Martijn Bos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Martijn Bos. The network helps show where J. Martijn Bos may publish in the future.

Co-authorship network of co-authors of J. Martijn Bos

This figure shows the co-authorship network connecting the top 25 collaborators of J. Martijn Bos. A scholar is included among the top collaborators of J. Martijn Bos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Martijn Bos. J. Martijn Bos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Crotti, Lia, Federica Dagradi, J. Martijn Bos, et al.. (2024). Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes, Transgenic Rabbits, and Patients. Circulation. 150(7). 531–543. 16 indexed citations
2.
Bos, J. Martijn, et al.. (2023). Clinical Course of Patients with Hypertrophic Cardiomyopathy Away from Tertiary Referral Care. ESC Heart Failure. 10(3). 1919–1927. 6 indexed citations
3.
Bos, J. Martijn, Aaron L. Baggish, Dermot Phelan, et al.. (2023). Return-to-Play for Elite Athletes With Genetic Heart Diseases Predisposing to Sudden Cardiac Death. Journal of the American College of Cardiology. 82(8). 661–670. 23 indexed citations
4.
Bos, J. Martijn, et al.. (2023). Fatal Cardiac Arrhythmias During Electronic Gaming in Patients With Genetically Mediated Heart Diseases. Journal of the American College of Cardiology. 82(7). 603–611. 1 indexed citations
5.
Bos, J. Martijn, Christian van der Werf, Shubhayan Sanatani, et al.. (2023). PO-01-134 AN INTERNATIONAL MULTICENTER COHORT STUDY ON BETA-BLOCKER FREE TREATMENT STRATEGIES FOR CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA. Heart Rhythm. 20(5). S169–S170. 2 indexed citations
6.
Bos, J. Martijn, Surendra Dasari, Kenneth L. Johnson, et al.. (2023). Proteomic and phosphoproteomic analyses of myectomy tissue reveals difference between sarcomeric and genotype-negative hypertrophic cardiomyopathy. Scientific Reports. 13(1). 14341–14341. 3 indexed citations
7.
Chen, David, Nakeya Dewaswala, Shivaram P. Arunachalam, et al.. (2022). Deep Neural Network for Cardiac Magnetic Resonance Image Segmentation. Journal of Imaging. 8(5). 149–149. 8 indexed citations
8.
Goldenberg, Ilan, J. Martijn Bos, Anita Y. Chen, et al.. (2021). Risk Prediction in Women With Congenital Long QT Syndrome. Journal of the American Heart Association. 10(14). e021088–e021088. 8 indexed citations
9.
Giudicessi, John R., Dan Ye, Hennie Bikker, et al.. (2021). A phenotype-enhanced variant classification framework to decrease the burden of missense variants of uncertain significance in type 1 long QT syndrome. Heart Rhythm. 19(3). 435–442. 10 indexed citations
10.
Giudicessi, John R., J. Martijn Bos, Conner Galloway, et al.. (2021). Artificial Intelligence–Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device. Circulation. 143(13). 1274–1286. 74 indexed citations
11.
Bos, J. Martijn, et al.. (2021). Return-to-Play for Athletes With Long QT Syndrome or Genetic Heart Diseases Predisposing to Sudden Death. Journal of the American College of Cardiology. 78(6). 594–604. 32 indexed citations
12.
Siontis, Konstantinos C., Kan Liu, J. Martijn Bos, et al.. (2021). DETECTION OF HYPERTROPHIC CARDIOMYOPATHY BY ARTIFICIAL INTELLIGENCE-ENABLED ELECTROCARDIOGRAPHY IN CHILDREN AND ADOLESCENTS. Journal of the American College of Cardiology. 77(18). 3247–3247. 1 indexed citations
13.
Bos, J. Martijn, Richard D. Bagnall, John R. Giudicessi, et al.. (2020). Clinical Utility of a Phenotype-Enhanced MYH7 -Specific Variant Classification Framework in Hypertrophic Cardiomyopathy Genetic Testing. Circulation Genomic and Precision Medicine. 13(5). 453–459. 10 indexed citations
14.
Sugrue, Alan, Martin van Zyl, Benjamin W. Eidem, et al.. (2020). Echocardiography-Guided Risk Stratification for Long QT Syndrome. Journal of the American College of Cardiology. 76(24). 2834–2843. 15 indexed citations
15.
Zhou, Wei, J. Martijn Bos, Dan Ye, et al.. (2019). Induced Pluripotent Stem Cell–Derived Cardiomyocytes from a Patient with MYL2-R58Q-Mediated Apical Hypertrophic Cardiomyopathy Show Hypertrophy, Myofibrillar Disarray, and Calcium Perturbations. Journal of Cardiovascular Translational Research. 12(5). 394–403. 33 indexed citations
16.
Anderson, Jason H., Jamie D. Kapplinger, Teresa Kruisselbrink, et al.. (2016). Evaluation of the Mayo Clinic Phenotype-Based Genotype Predictor Score in Patients with Clinically Diagnosed Hypertrophic Cardiomyopathy. Journal of Cardiovascular Translational Research. 9(2). 153–161. 40 indexed citations
17.
Hebl, Virginia B., J. Martijn Bos, Ann L. Oberg, et al.. (2012). Abstract 11099: Transcriptome Profiling of Surgical Myectomy Tissue from Patients with Hypertrophic Cardiomyopathy Reveals Marked Overexpression of ACE2. Circulation. 126. 2 indexed citations
18.
Johnson, Jonathan N., Camilla Grifoni, J. Martijn Bos, et al.. (2011). Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathy. European Heart Journal. 32(9). 1114–1120. 79 indexed citations
19.
Arimura, Takuro, J. Martijn Bos, Akinori Sato, et al.. (2009). Cardiac Ankyrin Repeat Protein Gene (ANKRD1) Mutations in Hypertrophic Cardiomyopathy. Journal of the American College of Cardiology. 54(4). 334–342. 114 indexed citations
20.
Landstrom, Andrew P., Michelle S. Parvatiyar, J. Martijn Bos, et al.. (2007). Abstract 539: Molecular and Functional Characterization of Novel Hypertrophic Cardiomyopathy Susceptibility Mutations in TNNC1-Encoded Troponin C. Circulation. 116. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jens Mogensen Breakdown of academic impact, for papers by Juan R. Gimeno Breakdown of academic impact, for papers by Philippe Charron Breakdown of academic impact, for papers by Andrea Mazzanti Breakdown of academic impact, for papers by Nathan Mewton Breakdown of academic impact, for papers by Juha Koskenvuo Breakdown of academic impact, for papers by Mika Laine Breakdown of academic impact, for papers by Yüng-Zu Tseng Breakdown of academic impact, for papers by Dana Leifer Breakdown of academic impact, for papers by Vincent Probst
Rankless by CCL
2026